The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The global Gene Delivery System market was valued at US$ 7077.6 million in 2023 and is anticipated to reach US$ 39700 million by 2030, witnessing a CAGR of 27.6% during the forecast period 2024-2030.
Gene Delivery System is widely used for Neurological Diseases, Cancer, etc. The Neurological Diseases occupied about 60% of market share, the cancer occupied about 35%.
North America is the largest consumption place, with a consumption market share nearly 62% in 2019. Following North America, Europe and Asia-Pacific occupied about 35% revenue market share in 2019.Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen,Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute and etc. are the leaders of the industry. In 2019,top 3 companies occupied over 80% of revenue market share.
This report aims to provide a comprehensive presentation of the global market for Gene Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Delivery System.
Report Scope
The Gene Delivery System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Biogen
- Novartis
- Gilead Sciences
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Amgen
- Spark Therapeutics
- Akcea Therapeutics
- bluebird bio
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
- Human Stem Cells Institute
Segment by Type
- Viral Gene Delivery System
- Non-viral Gene Delivery System
Segment by Application
- Neurological Diseases
- Cancer
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Delivery System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Delivery System Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.3 Market by Application
1.3.1 Global Gene Delivery System Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Delivery System Market Perspective (2019-2030)
2.2 Gene Delivery System Growth Trends by Region
2.2.1 Global Gene Delivery System Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Delivery System Historic Market Size by Region (2019-2024)
2.2.3 Gene Delivery System Forecasted Market Size by Region (2025-2030)
2.3 Gene Delivery System Market Dynamics
2.3.1 Gene Delivery System Industry Trends
2.3.2 Gene Delivery System Market Drivers
2.3.3 Gene Delivery System Market Challenges
2.3.4 Gene Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Delivery System Players by Revenue
3.1.1 Global Top Gene Delivery System Players by Revenue (2019-2024)
3.1.2 Global Gene Delivery System Revenue Market Share by Players (2019-2024)
3.2 Global Gene Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Delivery System Revenue
3.4 Global Gene Delivery System Market Concentration Ratio
3.4.1 Global Gene Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Delivery System Revenue in 2023
3.5 Gene Delivery System Key Players Head office and Area Served
3.6 Key Players Gene Delivery System Product Solution and Service
3.7 Date of Enter into Gene Delivery System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Delivery System Breakdown Data by Type
4.1 Global Gene Delivery System Historic Market Size by Type (2019-2024)
4.2 Global Gene Delivery System Forecasted Market Size by Type (2025-2030)
5 Gene Delivery System Breakdown Data by Application
5.1 Global Gene Delivery System Historic Market Size by Application (2019-2024)
5.2 Global Gene Delivery System Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Delivery System Market Size (2019-2030)
6.2 North America Gene Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Delivery System Market Size by Country (2019-2024)
6.4 North America Gene Delivery System Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Delivery System Market Size (2019-2030)
7.2 Europe Gene Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Delivery System Market Size by Country (2019-2024)
7.4 Europe Gene Delivery System Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Delivery System Market Size (2019-2030)
8.2 Asia-Pacific Gene Delivery System Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Delivery System Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Delivery System Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Delivery System Market Size (2019-2030)
9.2 Latin America Gene Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Delivery System Market Size by Country (2019-2024)
9.4 Latin America Gene Delivery System Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Delivery System Market Size (2019-2030)
10.2 Middle East & Africa Gene Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Delivery System Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Delivery System Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Delivery System Introduction
11.1.4 Biogen Revenue in Gene Delivery System Business (2019-2024)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Delivery System Introduction
11.2.4 Novartis Revenue in Gene Delivery System Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Detail
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene Delivery System Introduction
11.3.4 Gilead Sciences Revenue in Gene Delivery System Business (2019-2024)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Detail
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene Delivery System Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene Delivery System Business (2019-2024)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Detail
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene Delivery System Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2019-2024)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene Delivery System Introduction
11.6.4 Amgen Revenue in Gene Delivery System Business (2019-2024)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Detail
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene Delivery System Introduction
11.7.4 Spark Therapeutics Revenue in Gene Delivery System Business (2019-2024)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Detail
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene Delivery System Introduction
11.8.4 Akcea Therapeutics Revenue in Gene Delivery System Business (2019-2024)
11.8.5 Akcea Therapeutics Recent Development
11.9 bluebird bio
11.9.1 bluebird bio Company Detail
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Gene Delivery System Introduction
11.9.4 bluebird bio Revenue in Gene Delivery System Business (2019-2024)
11.9.5 bluebird bio Recent Development
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Detail
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Gene Delivery System Introduction
11.10.4 Sunway Biotech Revenue in Gene Delivery System Business (2019-2024)
11.10.5 Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Detail
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Gene Delivery System Introduction
11.11.4 SIBIONO Revenue in Gene Delivery System Business (2019-2024)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Detail
11.12.2 AnGes Business Overview
11.12.3 AnGes Gene Delivery System Introduction
11.12.4 AnGes Revenue in Gene Delivery System Business (2019-2024)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Detail
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Gene Delivery System Introduction
11.13.4 Orchard Therapeutics Revenue in Gene Delivery System Business (2019-2024)
11.13.5 Orchard Therapeutics Recent Development
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Detail
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Gene Delivery System Introduction
11.14.4 Human Stem Cells Institute Revenue in Gene Delivery System Business (2019-2024)
11.14.5 Human Stem Cells Institute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
